Prostate-Specific Membrane Antigen–Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer

Radiohalogenated agents are often the first line of pursuit in the development of new radiopharmaceuticals—whether antibodies, peptides, or small molecules—because of their ease of synthesis, lack of substantial steric perturbation of the original affinity agent (in some cases, providing enhanced af...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Nucl Med
Päätekijät: Rowe, Steven P., Drzezga, Alexander, Neumaier, Bernd, Dietlein, Markus, Gorin, Michael A., Zalutsky, Michael R., Pomper, Martin G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Society of Nuclear Medicine 2016
Aiheet:
Supplement
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093916/
https://ncbi.nlm.nih.gov/pubmed/27694179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.115.170175
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia